Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 3/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13684329 | 1.00 | CYP19A1 (0.33) | CYP19A1MEN1KMT2AGAATDP1 | |
| SCHEMBL12534609 | 0.88 | MEN1 (0.37) | CYP19A1MEN1KMT2AGAAALDH1A1 | |
| SCHEMBL24777091 | 0.87 | HRH3 (0.32) | CYP19A1HRH3 | |
| SCHEMBL13532545 | 0.84 | MEN1 (0.42) | CYP19A1MEN1KMT2ATDP1ALDH1A1 | |
| SCHEMBL13532895 | 0.83 | SMN1; SMN2 (0.30) | SMN1; SMN2 | |
| SCHEMBL24303333 | 0.81 | POLB (0.42) | MEN1KMT2AGAATDP1ALDH1A1 | |
| SCHEMBL13684308 | 0.80 | MAPK1 (0.37) | CYP19A1GAATDP1ALDH1A1HPGD | |
| SCHEMBL21016807 | 0.80 | MEN1 (0.31) | MEN1KMT2AALDH1A1HPGD | |
| SCHEMBL13532554 | 0.80 | SMN1; SMN2 (0.39) | MEN1KMT2AALDH1A1HPGDMAPT | |
| SCHEMBL12308315 | 0.80 | SMN1; SMN2 (0.39) | MEN1KMT2AALDH1A1HPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4108704-A1 | POLYIMIDE COPOLYMER AND POLYIMIDE FILM USING THE SAME | Jeonju University Office of Industry-University Cooperation (KR) | 2022-12-28 | — | — | EP | disclosed |
| US-9546169-B2 | Redox active triangular organic materials | NORTHWESTERN UNIVERSITY (US) | 2017-01-17 | — | — | US | disclosed |
| US-20160130271-A1 | REDOX ACTIVE TRIANGULAR ORGANIC MATERIALS | NORTHWESTERN UNIVERSITY | 2016-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160130271-A1 | REDOX ACTIVE TRIANGULAR ORGANIC MATERIALS | MT-ND1, NQO1, GPX4 | CYP19A1 1599/4885MEN1 4586/4885KMT2A 4231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.